Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Gallego

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cell & Bioscience|March 17, 2020
Circular RNA expression profile in blood according to ischemic stroke etiologyAiora Ostolaza, Idoia Blanco-Luquin, Amaya Urdánoz-Casado, et al.
Journal of Materials Chemistry. C|May 19, 2025
Covalent carbon nanodot-azobenzene hybrid photoswitches: the impact of <i>meta</i>/<i>para</i> connectivity and sp<sup>3</sup> spacer on photophysical propertiesPaul P Debes, Dominic Schatz, Yagmur Aydogan-Sun, et al.
Biomed Research International|May 8, 2014
An ANOCEF genomic and transcriptomic microarray study of the response to irinotecan and bevacizumab in recurrent glioblastomasJulien Laffaire, Anna Luisa Di Stefano, Olivier Chinot, et al.
Frontiers in Neurology|March 13, 2023
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic strokeMacarena Hernández-Jiménez, Francisco Abad-Santos, Ian Cotgreave, et al.
Journal of Neuro-Oncology|December 10, 2014
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumabAnna Luisa Di Stefano, Marianne Labussiere, Giuseppe Lombardi, et al.
Plos One|August 1, 2025
The YoungFitT project: Study protocol for a randomized mixed-methods trial of physical exercise and mind-body interventions, with or without virtual reality, in university studentsSamira Rostami, Adrià Bermudo-Gallaguet, Neus Camins-Vila, et al.
Neuro-Oncology|August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Nature Medicine|February 12, 2019
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastomaKurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.
Cell Reports. Medicine|June 27, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomasSara Labiano, Javier Marco-Sanz, Iker Ausejo-Mauleon, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cell & Bioscience|March 17, 2020
Circular RNA expression profile in blood according to ischemic stroke etiologyAiora Ostolaza, Idoia Blanco-Luquin, Amaya Urdánoz-Casado, et al.
Journal of Materials Chemistry. C|May 19, 2025
Covalent carbon nanodot-azobenzene hybrid photoswitches: the impact of <i>meta</i>/<i>para</i> connectivity and sp<sup>3</sup> spacer on photophysical propertiesPaul P Debes, Dominic Schatz, Yagmur Aydogan-Sun, et al.
Biomed Research International|May 8, 2014
An ANOCEF genomic and transcriptomic microarray study of the response to irinotecan and bevacizumab in recurrent glioblastomasJulien Laffaire, Anna Luisa Di Stefano, Olivier Chinot, et al.
Frontiers in Neurology|March 13, 2023
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic strokeMacarena Hernández-Jiménez, Francisco Abad-Santos, Ian Cotgreave, et al.
Journal of Neuro-Oncology|December 10, 2014
VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumabAnna Luisa Di Stefano, Marianne Labussiere, Giuseppe Lombardi, et al.
Plos One|August 1, 2025
The YoungFitT project: Study protocol for a randomized mixed-methods trial of physical exercise and mind-body interventions, with or without virtual reality, in university studentsSamira Rostami, Adrià Bermudo-Gallaguet, Neus Camins-Vila, et al.
Neuro-Oncology|August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Nature Medicine|February 12, 2019
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastomaKurt A Schalper, Maria E Rodriguez-Ruiz, Ricardo Diez-Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.
Cell Reports. Medicine|June 27, 2025
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomasSara Labiano, Javier Marco-Sanz, Iker Ausejo-Mauleon, et al.
Pageof 5